RSC Advances
Paper
C17H13ClN2O2S, % C, 59.21; H, 3.80; N, 8.12. Found, %: C, 59.20;
H, 3.78; N, 8.11.
C
21H18N4O3S; % C, 62.05; H, 4.46; N, 13.78. Found % C, 62.09;
H, 4.45; N, 13.79.
30-(4-Methoxyphenyl)-5-chloro-30-phenylspiro[3H-indole-3,20-
5-Bromo-30-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyr-
thiazolidine]-2,40-(1H)-dione (4k). Mp 186–188 ꢁC (MeOH). IR azol-4-yl)-spiro[3H-indole-3,20-thiazolidine]-2,40-(1H) dione (4r).
(CHCl3) nmax: 3448, 3224, 2931, 2835, 1736, 1608, 1597, 1504, Mp 333 ꢁC (MeOH). 1H NMR (300 MHz, DMSO-d6) d/ppm: 2.50
1462, 1292, 1254, 1034, 837 cmꢀ1, 1H NMR (300 MHz, DMSO-d6) (s, 3H, CH3), 3.04 (s, 3H, N–CH3), 3.99 (d, 2H, CH2), 6.76–7.79
d/ppm: 2.48 (s, 3H, CH3), 3.79 (q, 2H, CH2), 6.83–7.41 (m, 7H, (m, 8H, Ar–H), 10.93 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6)
Ar–H), 11.08 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6) d/ppm: d/ppm: 178.2, 173.7, 169.9, 163.8, 162.3, 159.4, 157.1, 154.7,
173.8, 163.8, 157.9, 145.9, 133.9, 124.6, 123.9, 122.2, 120.0, 148.5, 146.8, 131.1, 129.8, 128.3, 126.6, 124.3, 123.2, 70.1, 37.4,
115.2, 113.9, 87.9, 55.8, 32.5. Anal. calcd for C17H13ClN2O3S, % 17.0, 16.7. Anal. calcd for C21H17BrN4O3S; % C, 51.97; H,
C, 56.59; H, 3.63; N, 7.76. Found, %: C, 56.57; H, 3.62; N, 7.74. 3.53; N, 11.54. Found % C, 51.89; H, 3.56; N, 11.59.
5-Bromo-30-phenylspiro[indoline-3,20-thiazolidine]-2,40-
5-Methyl-30-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-
dione (4l). Mp 306 ꢁC (MeOH). 1H NMR (300 MHz, DMSO-d6) d/ pyrazol-4-yl)-spiro[3H-indole-3,20-thiazolidine]-2,40-(1H) dione
1
ꢁ
ppm: 3.8 (s, 2H, CH2), 6.92–8.16 (m, 8H, Ar–H), 11.17 (s, 1H, (4s). Mp 328–330 C (MeOH). H NMR (300 MHz, DMSO-d6) d/
NH). 13C NMR (100 MHz, DMSO-d6) d/ppm: 179.6, 174.4, 154.9, ppm: 2.67 (s, 3H, CH3), 2.73 (s, 3H, N–CH3), 4.44 (d, 2H, CH2),
140.4, 135.0, 134.6, 129.6, 125.2, 119.4, 114.1, 111.2, 110.9, 72.1, 6.74–7.97 (m, 8H, Ar–H), 10.65 (s, 1H, NH). 13C NMR (100 MHz,
38.5. Anal. calcd for C16H11BrN2O2S, % C, 51.21; H, 2.95; N, DMSO-d6) d/ppm: 177.7, 173.6, 165.4, 161.7, 157.8, 152.0, 149.3,
7.47. Found, %: C, 51.25; H, 2.93; N, 7.42.
132.2, 131.9, 129.8, 129.7, 129.2, 124.8, 116.0, 115.6, 97.9, 69.5,
49.0, 31.1, 18.1, 14.2. Anal. calcd for C22H20N4O3S; % C, 62.84;
30-Benzyl-5-bromospiro[indoline-3,20-thiazolidine]-2,40-
dione (4m). Mp 190–192 ꢁC (MeOH). 1H NMR (300 MHz, DMSO- H, 4.79; N, 13.32. Found % C, 62.85; H, 4.76; N, 13.39.
d6) d/ppm: 3.31 (d, 2H, benzyl CH2), 4.00 (d, 2H, CH2), 6.71–8.00
30-(1H-Benzimidazol-2-yl)-spiro-[3H-indole-3,20-thiazoli-
(m, 8H, Ar–H), 10.54 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6) dine]-2,40-(1H)-dione (4t). Mp 250 ꢁC (MeOH). 1H NMR (300
d/ppm: 178.5, 175.3, 152.3, 148.0, 146.3, 136.2, 135.9, 130.9, MHz, DMSO-d6) d/ppm: 4.81 (d, 2H, CH2), 6.72–8.35 (m, 8H, Ar–
125.3, 124.2, 115.0, 108.8, 80.6, 38.9, 31.1. Anal. calcd for C17
-
H), 10.75 (s, 1H, NH), 10.89 (s, 1H, NH). 13C NMR (100 MHz,
H13ClN2O2S, % C, 59.21; H, 3.80; N, 8.12. Found, %: C, 59.20; H, DMSO-d6) d/ppm: 177.6, 167.6, 157.8, 146.6, 141.5, 137.6, 131.0,
3.78; N, 8.11.
129.5, 129.3, 128.4, 126.0, 120.9, 104.9, 72.9, 32.9. Anal. calcd for
C17H12N4O2S; % C, 60.70; H, 3.60; N, 16.66. Found C, 60.71; H,
5-Methyl-30-phenylspiro[indoline-3,20-thiazolidine]-2,40-
dione (4n). Mp > 300 ꢁC (MeOH). 1H NMR (300 MHz, DMSO-d6) 3.55; N, 16.69.
d/ppm: 2.08 (s, 3H, CH3), 3.25 (d, 2H, CH2), 6.47–8.06 (m, 8H,
5-Chloro-30-(1H-benzimidazol-2-yl)-spiro-[3H-indole-3,20-
Ar–H), 10.94 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6) d/ppm: thiazolidine]-2,40-(1H)-dione (4u). Mp 265 ꢁC (MeOH). 1H NMR
180.0, 170.8, 157.0, 154.0, 146.8, 143.6, 125.8, 121.1, 118.3, (300 MHz, DMSO-d6) d/ppm: 3.38 (d, 1H, CH), 4.39 (d, 1H, CH),
117.8, 114.9, 108.7, 102.9, 71.8, 29.2. Anal. calcd for 6.72–7.78 (m, 7H, Ar–H), 10.12 (s, 1H, NH), 12.89 (s, 1H, NH).
C
17H14N2O2S, % C, 65.79; H, 4.55; N, 9.03. Found, %: C, 65.75; 13C NMR (100 MHz, DMSO-d6) d/ppm: 171.4, 167.6, 150.9, 145.0,
H, 4.54; N, 9.02.
139.2, 132.0, 130.2, 128.0, 127.2, 126.0, 123.8, 122.4, 118.0,
30-(4-Methyl)-5-methylspiro[3H-indole-3,20-thiazolidine]-2,40- 108.0, 65.3, 29.8. Anal. calcd for C17H11ClN4O2S; % C, 55.06; H,
1
(1H)-dione (4o). Mp 187–189 ꢁC (MeOH). H NMR (300 MHz, 2.99; N, 15.11. Found C, 55.01; H, 2.97; N, 15.09.
DMSO-d6) d/ppm: 1.68 (s, 3H, CH3), 2.48 (s, 3H, CH3), 3.76 (d,
5-Methyl-30-(1H-benzimidazol-2-yl)-spiro-[3H-indole-3,20-
2H, CH2), 6.56–7.41 (m, 7H, Ar–H), 11.08 (s, 1H, NH). 13C NMR thiazolidine]-2,40-(1H)-dione (4v). Mp 240 C (MeOH). H NMR
1
ꢁ
(100 MHz, DMSO-d6) d/ppm: 177.4, 165.9, 152.4, 150.4, 148.4, (300 MHz, DMSO-d6) d/ppm: 2.40 (s, 3H, CH3), 4.81 (d, 2H, CH2),
141.7, 134.1, 133.0, 130.0, 124.8, 124.2, 121.6, 117.3, 116.6, 71.7, 6.44–8.35 (m, 7H, ArH), 10.74 (s, 1H, NH), 10.98 (s, 1H, NH). 13
C
36.5, 31.0. Anal. calcd for C18H16N2O2S, % C, 66.64; H, 4.97; N, NMR (100 MHz, DMSO-d6) d/ppm: 174.2, 166.2, 164.4, 164.1,
8.64. Found, %: C, 66.65; H, 4.82; N, 8.62.
155.7, 155.4, 152.3, 150.5, 132.7, 128.4, 127.7, 124.7, 117.4,
116.5, 115.3, 105.4, 77.5, 35.7, 30.9. Anal. calcd for C18H14N4O2S,
30-(4-Fluorophenyl)-5-methylspiro[3H-indole-3,20-thiazoli-
dine]-2,40-(1H)-dione (4p). Mp 190–192 ꢁC (MeOH). 1H NMR % C, 61.70; H, 4.03; N, 15.99. Found, %: C, 61.65; H, 4.01; N,
(300 MHz, DMSO-d6) d/ppm: 1.68 (s, 3H, CH3), 2.68 (d, 2H, CH2), 15.92.
6.71–7.28 (m, 7H, ArH), 11.66 (s, 1H, NH). 13C NMR (100 MHz,
30-(1,3-Benzothiazol-2-yl)-spiro-[3H-indole-3,20-thiazolidine]
DMSO-d6) d/ppm: 20.9, 24.6, 32.6, 73.1, 116.08–140.34, 150.8, 2,40-(1H)-dione (4w). Mp 168 ꢁC (MeOH). 1H NMR (300 MHz,
167.2, 170.5, 118.02, 63.05. Anal. calcd for C17H13FN2O2S, % C, DMSO-d6) d/ppm: 4.41 (d, 1H, CH), 4.86 (d, 1H, CH), 6.97–7.65
62.18; H, 3.99; N, 8.53. Found, %: C, 62.15; H, 3.88; N, 8.52.
(m, 8H, Ar–H), 10.95 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6)
30-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)- d/ppm: 175.6, 170.6, 156.8, 143.6, 141.5, 136.6, 130.0, 129.5,
spiro[3H-indole-3,20-thiazolidine]-2,40-(1H) dione (4q). Mp 127.3, 126.4, 126.0, 121.9, 108.9, 74.9, 32.1. Anal. calcd for
1
ꢁ
320 C (MeOH). H NMR (300 MHz, DMSO-d6) d/ppm: 2.50 (s,
C17H11N3O2S2; C, 57.77; H, 3.14; N, 11.89. Found C, 57.70; H,
3H, CH3), 3.41 (s, 3H, N–CH3), 4.05 (d, 2H, CH2), 6.70–8.12 (m, 3.13; N, 11.85.
9H, Ar–H), 10.63 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6) d/ 5-Chloro-30-(1,3-benzothiazol-2-yl)-spiro-[3H-indole-3,20-
1
ꢁ
ppm: 175.8, 173.8, 165.6, 155.8, 148.4, 144.3, 143.8, 133.2, 131.7, thiazolidine]-2,40-(1H)-dione (4x). Mp 171 C (MeOH). H NMR
121.9, 121.0, 115, 9, 108.8, 72.4, 29.6, 22.0, 15.5. Anal. calcd for (300 MHz, DMSO-d6) d/ppm: 4.47 (d, 1H, CH), 4.84 (d, 1H, CH),
6.89–7.75 (m, 7H, Ar–H), 10.59 (s, 1H, NH). 13C NMR (100 MHz,
44168 | RSC Adv., 2020, 10, 44159–44170
This journal is © The Royal Society of Chemistry 2020